2 studies found for:    11352951 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Overcoming Endocrine Resistance in Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Fulvestrant;   Drug: Lapatinib;   Drug: Aromatase Inhibitors;   Drug: Placebo Lapatinib
2 Recruiting Prospective Study of UDP-gluconoryltransferase 2B17 Genotype as a Predictive Marker of Exemestane PK and PD
Condition: Breast Carcinoma
Intervention: Drug: Exemestane

Indicates status has not been verified in more than two years